Diovan and Skin hypertrophy - a phase IV clinical study of FDA data

Summary:

Skin hypertrophy is reported as a side effect among people who take Diovan (valsartan), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Magnevist, and have Nuclear magnetic resonance imaging abdominal.

The phase IV clinical study analyzes which people have Skin hypertrophy when taking Diovan. It is created by eHealthMe based on reports of 80,750 people who have side effects when taking Diovan from the FDA, and is updated regularly.

What is Diovan?

Diovan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 83,154 Diovan users. Check the latest studies of Diovan.

What is Skin hypertrophy?

Skin hypertrophy (skin cells enlarges) is found to be associated with 587 drugs and 548 conditions by eHealthMe. Check the latest studies of Skin hypertrophy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

80,750 people reported to have side effects when taking Diovan.
Among them, 69 people (0.09%) have Skin hypertrophy.

Among these 69 people:

How long have people been on Diovan when they have Skin hypertrophy? *

What is the gender of people who have Skin hypertrophy when taking Diovan? *

female: 55.07 %
male: 44.93 %

What is the age of people who have Skin hypertrophy when taking Diovan? *

What are other drugs people take besides Diovan? *

What are other side effects people have besides Skin hypertrophy? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 55 people, 79.71%
Pain: 47 people, 68.12%
Oedema Peripheral (superficial swelling): 37 people, 53.62%
Weakness: 35 people, 50.72%
Skin Induration (an abnormally hard spot or area on the skin): 34 people, 49.28%
Skin Tightness: 33 people, 47.83%
Skin Discoloration: 32 people, 46.38%
Rashes (redness): 32 people, 46.38%
Joint Range Of Motion Decreased (disease of joint movement): 30 people, 43.48%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 29 people, 42.03%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Abdominal: 23 people, 33.33%
Nuclear Magnetic Resonance Imaging Brain: 20 people, 28.99%
Diabetes: 5 people, 7.25%
Pain: 5 people, 7.25%
Blood Phosphorus Increased: 5 people, 7.25%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 7.25%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 5 people, 7.25%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 5.80%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 5.80%
Hepatic Neoplasm Malignant (liver cancer): 4 people, 5.80%

* Approximation only. Some reports may have incomplete information.

Do you take Diovan and have Skin hypertrophy?

- Check whether Skin hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diovan:

Diovan (83,154 reports)

Browse all side effects of Diovan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hypertrophy:

Skin hypertrophy (587 drugs)

Browse all the conditions that are associated with Skin hypertrophy:

Skin hypertrophy (548 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valsartan (the active ingredients of Diovan) and Diovan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.